Immune responses to the hepatitis C virus NS4A protein are profoundly influenced by the combination of the viral genotype and the host major histocompatibility complex. Free

Abstract

The interaction between the host major histocompatibility complex (MHC) and the genotype of the hepatitis C virus (HCV) was analysed using syntheticfull-length non-structural (NS) 4Aproteins, residues 1658–1712, of genotypes 1b, 2b, 3a, 4a and 5a. Human and murine antibodies specific for the five NS4A genotypes analysed focused on residues 1688–1707. In immunized B10 H-2 con- genic mice, the H-2, H-2 and H-2 haplotypes were good responders to NS4A, irrespective of the viral genotype. In contrast, the H-2 haplotype was a low or non-responder to all NS4A genotypes, except for genotype 2b. Also, H-2- and H-2-restricted NS4A genotype 1b-specific T-cells focused on residues 1670–1679 and 1683–1692, respectively, whereas H-2-restricted NS4A genotype 2b-specific T-cells focused on the carboxy terminus. Interestingly, H-2-restricted genotype 1b-specific T-cells did not cross-react with T-cell site analogues of seven other genotypes, whereas the H-2-restric- ted, genotype 1b-specific T-cells cross-reacted with genotypes 1a, 4a and 5a. Thus the combination of viral genotype and host MHC profoundly influences the ability to mount an HCV NS4A-specific immune response.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-11-2735
1997-11-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/11/9367358.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-11-2735&mimeType=html&fmt=ahah

References

  1. Bartenschlager R., Ahlborn L. L., Mous J., Jacobsen H. 1993; Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. Journal of Virology 67:3835–3844
    [Google Scholar]
  2. Bartenschlager R., Lohmann V., Wilkinson T., Koch J. O. 1995; Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. Journal of Virology 69:7519–7528
    [Google Scholar]
  3. Bhattacherjee V., Prescott L. E., Pike I., Rodgers B., Bell H., El-Zayadi A. R., Kew M. C., Conradie J., Lin C. K., Marsden H., Saeed A. A., Parker D., Yap P. -L., Simmonds P. 1995; Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. Journal of General Virology 76:1737–1748
    [Google Scholar]
  4. Botarelli P., Brunetto M. R., Minutello M. A., Calvo P., Unutmaz D., Weiner A. J., Choo Q. L., Shuster J. R., Kuo G., Bonino F., Abrignani S. 1993; T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104:580–587
    [Google Scholar]
  5. Bukh J., Purcell R. H., Miller R. H. 1993; At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proceedings of the National Academy of Sciences USA: 908234–8238
    [Google Scholar]
  6. Bukh J., Purcell R. H., Miller R. H. 1994; Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proceedings of the National Academy of Sciences USA: 918239–8243
    [Google Scholar]
  7. Chen Z., Berkower I., Wang R. Y. -H., Ching W. -M., Alter H. J., Shih W. -K. 1995; Genetic control of the murine humoral response to distinct epitopes of the hepatitis C virus core protein. Journal of Viral Hepatitis 2:9–17
    [Google Scholar]
  8. Diepolder H. M., Zachoval R., Hoffman R. M., Wierenga E. A., Sanantonio T., Jung M. -C., Eichenlaub D., Pape G. R. 1995; Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006–1007
    [Google Scholar]
  9. Erickson A. L., Houghton M., Choo Q. L., Weiner A. J., Ralston R., Muchmore E., Walker C. M. 1993; Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. Journal of Immunology 151:4189–4199
    [Google Scholar]
  10. Ferrari C., Valli A., Galati L., Penna A., Scaccaglia P., Giuberti T., Schianchi C., Missale G., Marin M. G., Fiaccadori F. 1994; T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286–295
    [Google Scholar]
  11. Grakoui A., McCourt D. W., Wychowski C., Feinstone S. M., Rice C. M. 1993a; Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. Journal of Virology 67:2832–2843
    [Google Scholar]
  12. Grakoui A., McCourt D. W., Wychowski C., Feinstone S. M., Rice C. M. 1993b; A second hepatitis C virus-encoded proteinase. Proceedings of the National Academy of Sciences USA: 9010583–10587
    [Google Scholar]
  13. Grakoui A., Wychowski C., Lin C., Feinstone S., Rice C. M. 1993c; Expression and identification of hepatitis C virus polyprotein cleavage products. Journal of Virology 67:1385–1395
    [Google Scholar]
  14. Harase I., Moriyama T., Kaneko T., Kita H., Nomura M., Suzuki G., Ohnishi H., Muto Y., Yazaki Y., Imawari M. 1995; Immune response to hepatitis C virus core protein in mice. Immunology and Cell Biology 73:346–352
    [Google Scholar]
  15. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Ohkoshi S., Shimotohno K. 1991; Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochemical and Biophysical Research Communications 175:220–228
    [Google Scholar]
  16. Hoffmann R. M., Diepolder H. M., Zachoval R., Zwiebel F. -M., Jung M. -C., Schloz S., Nitschko H., Riethmüller G., Pape G. R. 1995; Mapping of immunodominant CD4 + T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 21:632–638
    [Google Scholar]
  17. Iwata K., Wakita T., Okumura A., Yoshioka K., Takayanagi M., Wands J., Kakumu S. 1995; Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology 22:1057–1064
    [Google Scholar]
  18. Jung M. -C., Diepolder H. M., Spengler U., Wierenga E. A., Zachoval R., Hoffman R. M., Eichenlaub D., Frösner G., Will H., Pape G. R. 1995; Activation of a heterogenous hepatitis B (HB) core and e antigen-specific CD4 + T-cell population during seroconversion to anti- HBe and anti-HBs in hepatitis B virus infection. Journal of Virology 69:3358–3368
    [Google Scholar]
  19. Kakimi K., Kuribayashi K., Iwashiro M., Masuda T., Sakai M., Ling W., Kubo Y., Kobayashi H., Higo K., Seki M., Honda Y., Yamada E., Matsuura Y., Miyamura T., Okuma M., Ishimoto A. 1995; Hepatitis C virus core region: helper T cell epitopes recognized by BALB/c and C57BL/6 mice. Journal of General Virology 76:1205–1214
    [Google Scholar]
  20. Kato N., Sekiya H., Ootsuyama Y., Nakazawa T., Hijikata M., Ohkoshi S., Shimotohno K. 1993; Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. Journal of Virology 67:3923–3930
    [Google Scholar]
  21. Kato N., Ootsuyama Y., Sekiya H., Ohkoshi S., Nakazawa T., Hijikata M., Shimotohno K. 1994; Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. Journal of Virology 68:4776–4784
    [Google Scholar]
  22. Koskinas J., McFarlane B. M., Nouri A. K., Tibbs C. J., Mizokami M., Donaldson P. T., McFarlane I. G., Williams R. 1994; Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C. Gastroenterology 107:1436–1442
    [Google Scholar]
  23. Koziel M. J., Dudley D., Afdhal N., Choo Q. L., Houghton M., Ralston R., Walker B. D. 1993; Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. Journal of Virology 67: 7522–7532
    [Google Scholar]
  24. Koziel M. J., Dudley D., Afdhal N., Grakoui A., Rice C. M., Choo Q. -L., Houghton M., Walker B. D. 1995; cytotoxic T lymphocytes specific for the hepatitis C virus: identification of multiple epitopes and characterization of patterns of cytokine release. Journal of Clinical Investigation 96: 2311–2321
    [Google Scholar]
  25. Kuo G., Choo Q. L., Alter H. J., Gitnik G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E., Tegtmeier F., Bonino F., Columbo M., Lee W. S., Kou C., Berger K., Schuster J. R., Overby L. R., Bradley D. W., Houghton M. 1989; An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364
    [Google Scholar]
  26. Lagging L. M., Meyer K., Hoft D., Houghton M., Belshe R. B., Ray R. 1995; Immune responses to plasmid DNA encoding the hepatitis C virus core protein. Journal of Virology 69:5859–5863
    [Google Scholar]
  27. Lewicki H., Tishon A., Borrow P., Evans C. F., Gairin J. E., Hahn K. M., Jewell D. A., Wilson I. A., Oldstone M. B. 1995a; CTL escape viral variants. I. Generation and molecular characterization. Virology 210:29–40
    [Google Scholar]
  28. Lewicki H., Von Herrath M. G., Evans C. F., Whitton J. L., Oldstone M. B. 1995b; CTL escape viral variants. II. Biologic activity in vivo. Virology 211:443–450
    [Google Scholar]
  29. Machida A., Ohnuma H., Tsuda F., Munekata E., Tanaka T., Akahane Y., Okamoto H., Mishiro S. 1992; Two distinct subtypes of hepatitis-C virus defined by antibodies directed to the putative core protein. Hepatology 16:886–891
    [Google Scholar]
  30. Major M. E., Vitvitski L., Mink M. A., Schleff M., Whalen R. G., Trépo C., Inchauspé G. 1995; DNA-based immunization with chimeric vectors for the induction of immune response against the hepatitis C virus nucleocapsid. Journal of Virology 69:5798–5805
    [Google Scholar]
  31. Maruyama T., Iino S., Koike K., Yasuda K., Milich D. R. 1993a; Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology 105:1141–1151
    [Google Scholar]
  32. Maruyama T., McLachlan A., Iino S., Koike K., Kurokawa K., Milich D. R. 1993b; The serology of chronic hepatitis B infection revisited. Journal of Clinical Investigation 91:2586–2595
    [Google Scholar]
  33. Milich D. R., McLachlan A., Thornton G. B., Hughes J. L. 1987; Immune response to hepatitis B virus core antigen HBcAg: localization of T cell recognition sites within HBcAg/HBeAg. Journal of Immunology 139:1223–1231
    [Google Scholar]
  34. Milich D. R., Jones J., Hughes J. L., Price J., Raney A. K., McLachlan A. 1990; Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?. Proceedings of the National Academy of Sciences USA: 876599–6603
    [Google Scholar]
  35. Milich D. R., Peterson D. L., Schödel F., Jones J. E., Hughes J. L. 1995; Preferential recognition of hepatitis B nucleocapsid antigens by Th1 and Th2 cells is epitope and major histocompatibility complex dependent. Journal of Virology 69:2776–2785
    [Google Scholar]
  36. Minutello M. A., Pileri P., Unutmaz D., Censini S., Kuo G., Houghton M., Brunetto M. R., Bonino F., Abrignani S. 1993; Compart- mentalization of T lymphocytes to the site of disease : intrahepatic CD4 + T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. Journal of Experimental Medicine 178:17–25
    [Google Scholar]
  37. Sällberg M., Norder H., Weiland O., Magnius L. O. 1989; Immunoglobulin isotypes of anti-HBc and anti-HBe and HBV DNA elimination in acute hepatitis B. Journal of Medical Virology 29:296–302
    [Google Scholar]
  38. Sällberg M., Rudén U., Magnius L. O., Norrby E., Wahren B. 1991; Rapid ‘tea-bag’ peptide synthesis using 9-fluorenylmethoxy- carbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunology Letters 30:59–68
    [Google Scholar]
  39. Sällberg M., Ruden U., Wahren B., Magnius L. O. 1992; Immunodominant regions within the hepatitis-C virus core and putative matrix proteins. Journal of Clinical Microbiology 30:1989–1994
    [Google Scholar]
  40. Sällberg M., Rudén U., Wahren B., Magnius L. O. 1993; Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins : identification of an IgG3 restricted recognition site within the envelope 1 protein. Clinical and Experimental Immunology 91:489–494
    [Google Scholar]
  41. Sällberg M., Zhang Z. -X., Chen M., Jin L., Birkett A., Peterson D. L., Milich D. R. 1996; Immunogenicity and antigenicity of the ATPase/helicase domain of the hepatitis C virus non-structural 3 protein. Journal of General Virology 77:2721–2728
    [Google Scholar]
  42. Satoh S., Tanji Y., Hijikata M., Kimura K., Shimotohno K. 1995; The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A. Journal of Virology 69:4255–4260
    [Google Scholar]
  43. Shimizu Y., Yamaji K., Masuho Y., Yokota T., Inoue H., Sudo K., Satoh S., Shimotohno K. 1996; Identification of the sequence on Ns4a required for enhanced cleavage of the Ns5a/5b site by hepatitis C virus Ns3 protease. Journal of Virology 70:127–132
    [Google Scholar]
  44. Simmonds P., Rose K. A., Graham S., Chan S. W., McOmish F., Dow B. C., Follett E. A., Yap P. L., Marsden H. 1993; Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV) : use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. Journal of Clinical Microbiology 31:1493–1503
    [Google Scholar]
  45. Weiner A. J., Brauer M. J., Rosenblatt J., Richman K. H., Tung J., Crawford K., Bonino F., Saracco G., Choo Q. L., Houghton M., Han J. H. 1991; Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180:842–848
    [Google Scholar]
  46. Weiner A. J., Geysen H. M., Christopherson C., Hall J. E., Mason T. J., Saracco G., Bonino F., Crawford K., Marion C. D., Crawford K. A., Brunetto M., Barr P. J., Miyamura T., Mchutchinson J., Houghton M. 1992; Evidence for immune selection of hepatitis-C virus (HCV) putative envelope glycoprotein variants - potential role in chronic HCV infections. Proceedings of the National Academy of Sciences USA: 893468–3472
    [Google Scholar]
  47. Weiner A. J., Erickson A. L., Kansopon J., Muchmore E., Hughes A. L., Houghton M., Walker C. M. 1995; Persistent hepatitis C virus infection in an infected chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proceedings of the National Academy of Sciences USA: 922755–2759
    [Google Scholar]
  48. Windhagen A., Schloz C., Höllsberg P., Fukaura H., Sette P., Hafler D. A. 1995; Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2:373–380
    [Google Scholar]
  49. Zhang Z. X., Yun Z. B., Chen M., Sönnerborg A., Sällberg M. 1994; Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction. Journal of Medical Virology 45:50–55
    [Google Scholar]
  50. Zhang Z. X., Chen M., Weiland O., Sönnerborg A., Sällberg M. 1995; Distinguishing acute from symptomatic chronic hepatitis C virus (HCV) infection by site directed serology of the HCV structural proteins. Journal of Infectious Diseases 171:1356–1359
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-11-2735
Loading
/content/journal/jgv/10.1099/0022-1317-78-11-2735
Loading

Data & Media loading...

Most cited Most Cited RSS feed